Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Life Sci ; 77(23): 2879-86, 2005 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-16002097

RESUMO

The C825T polymorphism of the beta-3 subunit of the protein G (GNB3) has been related to an increased activity of the Na+/H+ exchanger (NHE-1) through the synthesis of an anomalous hyperactive protein. Because of the important role of this system in essential hypertension (EH), we analysed the distribution of the different genotypes of this polymorphism in normotensive subjects (NS) and essential hypertensive patients (EHP), their relationship with the condition of salt sensitivity, plasma sodium and potassium concentrations and plasma renin activity (PRA) in EHP. 144 subjects (78 EHP and 76 NS) were studied. Salt sensitivity was assessed by the rapid protocol of Weinberger and genotype determination for GNB3 C825T polymorphism was performed by PCR. The distribution of the different genotypes was similar among EHP (CC 37.2%; CT 41.1%; TT 16.7%) and NS (CC 32.9%; CT 55.3%; TT 11.8%). In regard to general characteristics of EHP (including blood pressure levels) and the condition of salt sensitivity, there were no differences among the different genotypes. Plasma sodium concentration was higher and plasma potassium was lower in TT patients (141.0+/-1.7 and 3.7+/-0.1) than in CC patients (139.1+/-1.9 and 4.0+/-0.3) p<0.05. CT patients had intermediate values (139.9+/-1.9 and 3.9+/-0.2). PRA values were similar in the three genotypes as were the rest of analytical parameters studied. Our data demonstrate an association between the C825T polymorphism of the GNB3 and plasma sodium and potassium concentrations in EHP, as expression of an increase in NHE-1 activity, without modifications in PRA nor relationship with salt sensitivity.


Assuntos
Predisposição Genética para Doença , Proteínas Heterotriméricas de Ligação ao GTP/genética , Hipertensão/genética , Polimorfismo Genético , Potássio/sangue , Sódio/sangue , Adulto , Pressão Sanguínea/efeitos dos fármacos , Feminino , Humanos , Hipertensão/sangue , Masculino , Natriurese/efeitos dos fármacos , Renina/sangue , Cloreto de Sódio/farmacologia , Sódio na Dieta/administração & dosagem
2.
Med Clin (Barc) ; 122(7): 259-61, 2004 Feb 28.
Artigo em Espanhol | MEDLINE | ID: mdl-15012875

RESUMO

BACKGROUND AND OBJECTIVE: The HELLP syndrome is a rare form of preeclampsia with a variable presentation with substantial maternal and perinatal morbidity and mortality. The aim of this study was to determine its clinical and biological characteristics in our hospital. PATIENTS AND METHOD: An observational study of all cases of confirmed HELLP syndrome from 1999 to 2002 was carried out. RESULTS: There were 54 cases of HELLP syndrome. Mean maternal age was 30.06 (16-41) years. 57.4% were primiparous. Mean gestational age at diagnosis of HELLP syndrome was 31.75 (20-41) weeks. Symptoms and signs were dominated by the digestive ones. Hypertension was observed in all cases. 77.8% pregnancies were delivered by caesarean section. Mean birth weight was 1674.52 g (150-3800 g). There were 12 perinatal deaths and one maternal death. CONCLUSIONS: HELLP syndrome is an uncommon but potentially serious complication of pregnancy which is associated with an increased risk of adverse maternal and fetal outcomes. Management should be multidisciplinary and based on strict control by maternal and fetal symptoms.


Assuntos
Síndrome HELLP/diagnóstico , Complicações na Gravidez/diagnóstico , Resultado da Gravidez , Adulto , Análise Química do Sangue , Diagnóstico Diferencial , Feminino , Idade Gestacional , Síndrome HELLP/complicações , Síndrome HELLP/terapia , Testes Hematológicos , Humanos , Recém-Nascido , Doenças do Recém-Nascido/epidemiologia , Doenças do Recém-Nascido/etiologia , Gravidez , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/terapia
3.
Med. clín (Ed. impr.) ; 122(7): 259-261, mar. 2004.
Artigo em Es | IBECS | ID: ibc-30389

RESUMO

FUNDAMENTO Y OBJETIVO: El síndrome HELLP es una forma rara de preeclampsia de presentación variable que asocia un incremento de la morbilidad y mortalidad materna y perinatal. El objetivo de este estudio fue determinar las características clínicas y biológicas de los casos asistidos en nuestro hospital. PACIENTES Y MÉTODO: Estudio observacional de todas las pacientes con síndrome HELLP atendidas en un solo centro entre 1999 y 2002. RESULTADOS: Hubo 54 casos de síndrome HELLP. La edad materna fue de 30,06 años (extremos, 16-41) y el 57,4 por ciento eran primíparas. La edad gestacional al diagnóstico fue de 31,75 semanas (extremos, 20-41). Los síntomas y signos fueron predominantemente digestivos. La presencia de hipertensión fue común en todos los casos. En el 77,8 por ciento de los casos fue necesario practicar una cesárea. El peso medio de los recién nacidos fue de 1.674,52 g (150-3.800 g). Hubo 12 muertes perinatales y una muerte materna. CONCLUSIONES: Este síndrome es una complicación rara pero potencialmente grave del embarazo que asocia un riesgo aumentado de problemas maternos y fetales. Por consiguiente, su manejo debe ser multidisciplinario y basado en un control estricto de la clínica materna y fetal (AU)


Assuntos
Gravidez , Adulto , Recém-Nascido , Feminino , Humanos , Resultado da Gravidez , Síndrome HELLP , Complicações na Gravidez , Análise Química do Sangue , Diagnóstico Diferencial , Doenças do Recém-Nascido , Idade Gestacional , Testes Hematológicos
4.
Med Clin (Barc) ; 119(14): 527-30, 2002 Oct 26.
Artigo em Espanhol | MEDLINE | ID: mdl-12421519

RESUMO

BACKGROUND: Glucose effectiveness (SG) is a parameter that indicates the glucose ability to clearing itself from the plasma independently of insulin's action. Our purpose was to analyze the cluster characteristics associated with the metabolic syndrome in a group of non-obese, recent-onset hypertensives and to test if there was a correlation with SG and the effectiveness of glucose at basal insulin point (GEZI). PATIENTS AND METHOD: We studied 36 patients with mild hypertension with normal basal glucose levels. We determined plasma lipid subfractions, apolipoproteins and urate levels. An intravenous glucose tolerance test (TTGI) and minimal model analysis according to Bergman was performed and SG, GEZI and insulin sensitivity (SI) were calculated. RESULTS: Patients with lower SG and GEZI had higher levels of total triglycerides (Tg) (r = 0.42; p = 0.01 and r = 0.48; p = 0.002, respectively) and triglycerides bind to VLDL (Tg-VLDL) (r = 0.40; p < 0.01 and r = 0.49; p = 0.002, respectively). When the cluster of metabolic syndrome was analyzed, SG was inversely related to uric acid levels and to the waist-hip index. However, SI was only related to the uric acid levels (r = 0.38; p = 0.01). CONCLUSIONS: In non-obese, recently diagnosed hypertensive patients, the SG parameter seems to be an early marker for the development of metabolic syndrome.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Glucose/uso terapêutico , Hipertensão/metabolismo , Insulina/análogos & derivados , Insulina/uso terapêutico , Síndrome Metabólica/tratamento farmacológico , Adulto , Idoso , VLDL-Colesterol/sangue , Estudos Transversais , Feminino , Glucose/administração & dosagem , Glucose/metabolismo , Intolerância à Glucose/metabolismo , Teste de Tolerância a Glucose/métodos , Humanos , Injeções Intravenosas , Insulina/administração & dosagem , Insulina/sangue , Insulina de Ação Prolongada , Masculino , Síndrome Metabólica/metabolismo , Pessoa de Meia-Idade , Fenótipo , Radioimunoensaio , Triglicerídeos/sangue , Ácido Úrico/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...